162 related articles for article (PubMed ID: 29038250)
1. Inhibition of IRAK1 Ubiquitination Determines Glucocorticoid Sensitivity for TLR9-Induced Inflammation in Macrophages.
Kong F; Liu Z; Jain VG; Shima K; Suzuki T; Muglia LJ; Starczynowski DT; Pasare C; Bhattacharyya S
J Immunol; 2017 Nov; 199(10):3654-3667. PubMed ID: 29038250
[TBL] [Abstract][Full Text] [Related]
2. β-TrCP-mediated IRAK1 degradation releases TAK1-TRAF6 from the membrane to the cytosol for TAK1-dependent NF-κB activation.
Cui W; Xiao N; Xiao H; Zhou H; Yu M; Gu J; Li X
Mol Cell Biol; 2012 Oct; 32(19):3990-4000. PubMed ID: 22851693
[TBL] [Abstract][Full Text] [Related]
3. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
4. Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways.
Jeong JJ; Jang SE; Hyam SR; Han MJ; Kim DH
Eur J Pharmacol; 2014 Oct; 740():652-61. PubMed ID: 24972244
[TBL] [Abstract][Full Text] [Related]
5. p16(INK4a) exerts an anti-inflammatory effect through accelerated IRAK1 degradation in macrophages.
Murakami Y; Mizoguchi F; Saito T; Miyasaka N; Kohsaka H
J Immunol; 2012 Nov; 189(10):5066-72. PubMed ID: 23066149
[TBL] [Abstract][Full Text] [Related]
6. IinQ attenuates systemic inflammatory responses via selectively impairing the Myddosome complex formation upon TLR4 ligation.
Kang K; Won M; Yuk JM; Park CY; Byun HS; Park KA; Lee SR; Kang YG; Shen HM; Lee IY; Hur GM
Biochem Pharmacol; 2016 Dec; 121():52-66. PubMed ID: 27664853
[TBL] [Abstract][Full Text] [Related]
7. CMRF-35-like molecule 3 preferentially promotes TLR9-triggered proinflammatory cytokine production in macrophages by enhancing TNF receptor-associated factor 6 ubiquitination.
Wu Y; Zhu X; Li N; Chen T; Yang M; Yao M; Liu X; Jin B; Wang X; Cao X
J Immunol; 2011 Nov; 187(9):4881-9. PubMed ID: 21940676
[TBL] [Abstract][Full Text] [Related]
8. A novel IRAK1-IKKε signaling axis limits the activation of TAK1-IKKβ downstream of TLR3.
Bruni D; Sebastia J; Dunne S; Schröder M; Butler MP
J Immunol; 2013 Mar; 190(6):2844-56. PubMed ID: 23396947
[TBL] [Abstract][Full Text] [Related]
9. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.
Kim IT; Ryu S; Shin JS; Choi JH; Park HJ; Lee KT
J Cell Biochem; 2012 Jun; 113(6):1936-46. PubMed ID: 22234926
[TBL] [Abstract][Full Text] [Related]
10. PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation.
Lee HJ; Chung KC
J Neuroinflammation; 2012 Dec; 9():271. PubMed ID: 23244239
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1β-induced IRAK1 ubiquitination is required for T
Hu Y; Xu F; Zhang R; Legarda D; Dai J; Wang D; Li H; Zhang Y; Xue Q; Dong G; Zhang H; Lu C; Mortha A; Liu J; Cravedi P; Ting A; Li L; Qi CF; Pierce S; Merad M; Heeger P; Xiong H
J Autoimmun; 2019 Aug; 102():50-64. PubMed ID: 31080014
[TBL] [Abstract][Full Text] [Related]
12. Kalopanaxsaponin B inhibits LPS-induced inflammation by inhibiting IRAK1 Kinase.
Joh EH; Jeong JJ; Kim DH
Cell Immunol; 2012 Sep; 279(1):103-8. PubMed ID: 23117333
[TBL] [Abstract][Full Text] [Related]
13. Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice.
Pauls E; Nanda SK; Smith H; Toth R; Arthur JSC; Cohen P
J Immunol; 2013 Sep; 191(5):2717-30. PubMed ID: 23918981
[TBL] [Abstract][Full Text] [Related]
14. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β-activated kinase 1 resistance limits glucocorticoid responsiveness to Toll-like receptor 4-mediated inflammation.
Kong F; Laryea G; Liu Z; Bhattacharyya S
Immunology; 2015 May; 145(1):136-49. PubMed ID: 25521315
[TBL] [Abstract][Full Text] [Related]
16. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Inflammatory Responses by
Cho YC; Vuong HL; Ha J; Lee S; Park J; Wibow AE; Cho S
Am J Chin Med; 2020; 48(5):1103-1120. PubMed ID: 32668965
[No Abstract] [Full Text] [Related]
18. MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice.
Jiang W; Liu J; Dai Y; Zhou N; Ji C; Li X
J Gastroenterol Hepatol; 2015 May; 30(5):933-43. PubMed ID: 25559563
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles.
Hirayama T; Tamaki Y; Takakubo Y; Iwazaki K; Sasaki K; Ogino T; Goodman SB; Konttinen YT; Takagi M
J Orthop Res; 2011 Jul; 29(7):984-92. PubMed ID: 21308757
[TBL] [Abstract][Full Text] [Related]
20. Pellino 2 is critical for Toll-like receptor/interleukin-1 receptor (TLR/IL-1R)-mediated post-transcriptional control.
Kim TW; Yu M; Zhou H; Cui W; Wang J; DiCorleto P; Fox P; Xiao H; Li X
J Biol Chem; 2012 Jul; 287(30):25686-95. PubMed ID: 22669975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
